Boehringer Ingelheim (Australia)
- World rank, all time
- #24,857 of 42,892
- Rank in Australia
- #456 of 656
- Research works
- 132 ▲ 21% vs 2013–17
- Citations
- 1.9k 14.8 per fractional work
- Top-10% rate
- 18.5% record average 16.5%
- Open access
- 41% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 22.5×. Every wedge is a field page.
- Veterinary 22.5×
- Immunology and Microbiology 4.9×
- Pharmacology, Toxicology and Pharmaceutics 4.2×
- Neuroscience 3.6×
- Chemistry 3.2×
- Biochemistry, Genetics and Molecular Biology 2.9×
- Medicine 1.9×
- Agricultural and Biological Sciences 1.3×
- Energy 1.3×
- Health Professions 1.3×
- Environmental Science 1.0×
- Physics and Astronomy 0.8×
- Dentistry 0.6×
- Engineering 0.4×
- Computer Science 0.3×
- Psychology 0.3×
- Materials Science 0.0×
- Social Sciences 0.0×
Who are the top researchers at Boehringer Ingelheim (Australia)?
Ranked on the composite score, Thomas Glaab lead among researchers whose main affiliation is Boehringer Ingelheim (Australia).
- 1 Thomas Glaab Australia · #785,328 worldwide 30 citations · 16 works
Which keywords describe research at Boehringer Ingelheim (Australia)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Depression, Clinical Guidelines, Cognitive Impairment, Synaptic Plasticity, Antidepressant, Ketamine and Monoclonal Antibodies.
- Therapeutic Antibodies
- Neurological Disorders
- Heart Failure
- Cancer
- Ketamine
- Antidepressant
- Cognitive Impairment
- Inflammation
- Depression
- Epidemiology
- Clinical Guidelines
- Public Health
- Synaptic Plasticity
- Genetics
- Monoclonal Antibodies
- Glycosylation
- Metabolic Syndrome
- Oxidative Stress
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 18 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 18 words, with their numbers
- Epidemiology4▲ 3.1×18 topics
- Depression2▲ 7.8×3 topics
- Clinical Guidelines2▲ 20×3 topics
- Inflammation2▲ 2.7×11 topics
- Public Health2▲ 3.9×7 topics
- Cognitive Impairment1▲ 18×2 topics
- Synaptic Plasticity1▲ 21×2 topics
- Antidepressant1▲ 183×1 topic
- Genetics1▲ 6.1×5 topics
- Ketamine1▲ 183×1 topic
- Monoclonal Antibodies1▲ 49×3 topics
- Cancer1▲ 3.0×4 topics
- Glycosylation1▲ 37×3 topics
- Heart Failure1▲ 8.8×6 topics
- Metabolic Syndrome1▲ 5.0×6 topics
- Neurological Disorders1▲ 6.8×3 topics
- Oxidative Stress1▲ 2.3×7 topics
- Therapeutic Antibodies1▲ 54×2 topics
Which research topics does Boehringer Ingelheim (Australia) publish most on?
By volume in 2022–2025: Treatment of Major Depression, Functional Brain Connectivity Studies, Helminth infection and control and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Treatment of Major Depression Pharmacology 1 works
- 2 Functional Brain Connectivity Studies Cognitive Neuroscience 1 works
- 3 Helminth infection and control Small Animals 1 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 5 Health and Medical Studies General Health Professions 0 works
- 6 Virus-based gene therapy research Genetics 0 works
- 7 Sustainable Building Design and Assessment Building and Construction 0 works
- 8 Medical and Health Sciences Research Public Health, Environmental and Occupational Health 0 works
- 9 Building Energy and Comfort Optimization Building and Construction 0 works
- 10 Protein purification and stability Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Boehringer Ingelheim (Australia)'s research output changed?
Output in 2018–2022 was 21% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in North Ryde
- ARC Centre of Excellence for Core to Crust Fluid Systems
- Canon (Australia)
- Covance (Australia)
- Smith & Nephew (Australia)
- Honeywell (Australia)
- Aristocrat (Australia)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.